More on GlaxoSmithKline (GSK +0.1%) Q3: Misses on revenue and EPS; core operating profit -15% to...

|About: GlaxoSmithKline (GSK)|By:, SA News Editor

More on GlaxoSmithKline (GSK +0.1%) Q3: Misses on revenue and EPS; core operating profit -15% to £1.97B. Earnings hurt by "demanding prior year comparisons" and continued weakness in Europe, where sales fell 9% as price pressure takes a toll. U.S. sales -6%, "reflecting genericisation and discontinuation of certain products." (PR)